Arrowhead Research | Kontanter Og Tilsvarende



Cash And Equivalent Lave om Dato
Agios Pharmaceuticals USD 76.25M 177.48M 2024-12
Alnylam Pharmaceuticals USD 966.43M 133.49M 2024-12
Arrowhead Research USD 51.79M 47.4M 2024-12
Incyte USD 1.69B 383.72M 2024-12
Ionis Pharmaceuticals USD 242.08M 92.53M 2024-12
Ligand Pharmaceuticals USD 72.31M 8.69M 2024-12
Merck USD 13.24B 1.35B 2024-12
Moderna USD 1.93B 283M 2024-12
Novartis USD 8.87B 4.74B 2024-12
Sarepta Therapeutics USD 1.1B 905.16M 2024-12
TG Therapeutics USD 179.89M 15.93M 2024-12
Ultragenyx Pharmaceutical USD 173.73M 23.11M 2024-12
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12
Xencor USD 40.88M 11.84M 2024-12



Arrowhead Research Kontanter Og Tilsvarende - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.